US Year Health Performance Express: Realizing a net profit of 167 million yuan, an increase of 998.00% over the same period of the previous year!

Recently, the leading medical check-up enterprise in the United States released the 2018 semi-annual report, and its operating income and profit have once again achieved substantial growth.

In the first half of 2018, the company achieved a total operating income of 3.49 billion yuan, an increase of 57.66% over the same period of the previous year; realized operating profit of 313 million yuan, an increase of 516.57% over the same period of the previous year; 1.2 billion yuan, an increase of 524.06% over the same period of the previous year; the net profit attributable to shareholders of listed companies was 167 million yuan, an increase of 998.00% over the same period of the previous year; the company's basic earnings per share was 0.05 yuan. Compared with the same period of last year, it increased by 100.00%. At the end of the first half of 2018, the company's total assets were 14.747 billion yuan, an increase of 18.17% from the beginning of 2018.

Mid-year health financial data for the first half of 2018

The semi-annual report shows that in the first half of 2018, the main reason for the substantial growth in the health performance of the US is still the market demand.

With the successive implementation of the national heavy-duty policies for preventive medicine and the upgrading of healthy consumption, the market demand for the health check-up industry is strong, showing a trend of blowout.

In the first half of 2018, the large-scale health scale of the United States continued to expand. While continuously consolidating and developing the group inspection market, it actively expanded the market for individual inspection and value-added services.

The product connotation has been expanded, and the quality service has been upgraded. New high-end physical examination products such as genetic testing, early tumor screening, coronary magnetic nucleus and liver superpower have been launched. The income has maintained rapid growth, the proportion of individual inspections has continued to rise, and the product structure continues to be optimized. The increase in volume and price will further increase the profits of listed companies and continuously enhance the company's core competitiveness.

The rapid expansion and expansion of the scale of the medical examination center have become the "winning secrets" of the US.

According to the data of the 2017 annual report, by the end of 2017, the company had 378 physical examination centers, 146 health holdings and 155 shares in the company. Ciming Medical Holdings
60 companies, 5 shareholdings; 2 MSI medical check-ups, 3 shares; 7 Aoya medical check-ups)

According to the report of 2018Q1, 19 new medical examination centers were newly incorporated in the first quarter. Since the medical examination center is generally concentrated in the third and fourth quarters, the new medical examination center will be faster in the first half of the year, and the end of the year is expected to be set at the end of the year. The number of 600 homes is expected to be realized, and by 2020, the US Health Year aims to build 1,000 medical examination centers.

The expansion of scale has brought about the rapid growth of medical examinations. The national chain model of the United States and the health of the multi-city district has more layouts for B-end customers, providing customers with more choices and conveniences for medical examinations.

In 2017, the number of health checkups in the United States reached 21.6 million, a year-on-year increase of 44%. It is expected to reach 30 million in 18 years and 100 million people by 2021. There is huge room for growth.

It is generally believed that the first half of the year (especially the first quarter) is the traditional off-season of the medical examination industry. The health of the United States has increased the promotion of off-season since the first quarter of last year. In 2017, the unit price of the evaluation was increased by 10%. In the first quarter of 2018, the promotion focused on high-end project testing, which led to a 44% increase in the number of inspections. The annual inspection is expected to account for 30%.

In terms of profit, the loss in the first quarter of 2018 was 98 million yuan, a loss of 7%, and the net profit of Q2 was 265 million yuan, a year-on-year increase of 98%.

In addition to the growth brought about by scale expansion, another important factor is the company's active expansion of the market for individual inspection and value-added services, which is reflected in the expansion of product connotation, the upgrading of quality services, and genetic testing, early tumor screening, coronary magnetic nucleus, Product structure optimization brought by high-end medical products such as liver super.

Following the "3650 package" and capsule gastroscopy, high-end physical examination items such as coronary magnetic resonance, genetic testing, capsule gastrointestinal endoscopy, and early detection of AD have been launched, and Zhifei Bio has settled in the cervical cancer vaccine value-added business to satisfy users. Azimuthal health service needs.

According to the opinion of the Pacific Medicine Research Report, the grassroots areas are the areas where the health of the United States is focused on the overall layout.

1) The health of the United States has basically surpassed the level of the local public hospitals in the basic city, and is ahead of the competition in terms of scale, production capacity, discounts, customer acquisition, etc., based on the company's full expansion to the 3, 4 and 5 lines, optimistic about the company's future layout and space.

2) The examination index of the medical examination center is refined, and the group's refined management ability is strong, ensuring the completion of performance targets.

3) The basic physical examination center achieves standardized replication, and the profit cycle has a shortened trend.

4) New projects and technologies such as genetic testing, remote reading, capsule gastrointestinaloscopy, respiratory sleep detection, and early detection of AD have already landed at the grassroots level, becoming an effective means to increase the volume and price of physical examination.

Arterial Blood Gas Collection Syringe

Arterial Blood Gas Collection Syringe,Arterial Blood Syringe,Syringe,arterial blood gas syringe,disposable syringe

Anesthesia Medical Co., Ltd. , https://www.jssinoanesthesias.com